Filter by: patients
Home > Community Treatment Reports and Side Effects > Prosed/DS Treatment Report
What is Prosed/DS?

Prosed/DS is an antispasmodic, urinary anti-infective, and analgesic combination used to treat the discomfort of certain types of urinary tract infections or diagnostic procedures.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Bladder problems 3 1 Efficacy_major
Interstitial Cystitis 2 1 Efficacy_moderate
Support urinary health 1 0
UTI (Urinary Tract Infection) 1 1 Efficacy_major

See all 4 patients currently taking Prosed/DS

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 0
Mild
 1
None
 2

Commonly reported side effects, conditions, and hospitalizations associated with Prosed/DS

Dry mouth (xerostomia) 1

Reported Dosages

  0 as needed 1mg as needed 4other as needed 1 other daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Prosed/DS (multiple reasons could be selected)
Reason # Patients Percentage of patients
Change in health plan coverage 1   Change in health plan coverage: 100%

See all 1 patient who’ve stopped taking Prosed/DS

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Prosed/DS

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0

Stopped Taking Prosed/DS

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Prosed/DS

Always
 2 67%
Usually
 1 33%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Prosed/DS

Very
 0 0%
Somewhat
 0 0%
A little
 0 0%
Not at all
 3 100%

Cost

Paid out of pocket

Cost of Prosed/DS

$200+
 1 33%
$100-199
 0 0%
$50-99
 1 33%
$25-49
 0 0%
< $25
 1 33%

Report created on May 28, 2012.